{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/red-cat-rcat/",
 "dataUrl": "https://clearank.com/stock/red-cat-rcat/data.json",
 "title": "Red Cat Holdings (RCAT) Stock Forecast & Price Target (2026)",
 "description": "Is Red Cat stock a buy? RCAT forecast 2026. The median analyst target is $15. One of the aerospace & defense names we cover.",
 "headline": "Red Cat Holdings Inc. (RCAT)",
 "published": "2026-11-09T13:02:04+00:00",
 "modified": "2026-11-10T13:19:23.454+00:00",
 "generated": "2026-11-11T13:24:38.789Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by Anthony Beachey, Financial Journalist; prices delayed by up to a minute.",
 "asset": {
  "ticker": "RCAT",
  "name": "Red Cat Holdings Inc.",
  "type": "Common Stock",
  "exchange": "NASDAQ",
  "currency": "USD",
  "sector": "Industrials",
  "industry": "Aerospace & Defense",
  "country": "United States",
  "website": "https://redcat.red"
 },
 "quote": {
  "price": 4.21,
  "previousClose": 4.5,
  "change": -0.29,
  "changePercent": -6.44,
  "open": 4.37,
  "high": 4.415,
  "low": 4.085,
  "volume": 4545100,
  "averageVolume": 6705710,
  "marketCap": 642927464,
  "fiftyTwoWeekHigh": 18.78,
  "fiftyTwoWeekLow": 3.25,
  "marketOpen": false,
  "asOf": "2026-11-11T13:23:55.000Z"
 },
 "statistics": {
  "pe": -5.773972811764234,
  "eps": -0.8,
  "dividendYield": 0,
  "beta": 1.675,
  "priceToSales": 8.986839,
  "priceToBook": 1.3642255,
  "revenueTtm": 71541000,
  "grossMargin": 0.16147407003813957,
  "returnOnEquity": -0.34402
 },
 "technicals": {
  "rsi": 39.77,
  "macd": -0.5293,
  "sma50": 6,
  "sma200": 10.11,
  "rsiSignal": "Bearish",
  "trend": "Bearish",
  "pricePosition": "Bearish",
  "macdSignal": "Bearish",
  "rating": "Bearish"
 },
 "analysis": {
  "rating": "Sell",
  "score": 31,
  "consensus": "Sell",
  "fairValue": null,
  "analystTarget": 15,
  "analystCount": 7,
  "wallStreetConsensus": "Buy",
  "generatedAt": "2026-11-11T13:23:55.000Z",
  "priceAtAnalysis": 4.21,
  "volatility": {
   "daily": 6.55,
   "risk": "volatile"
  }
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 1.97,
    "base": 3.75,
    "upside90th": 7.11
   },
   {
    "year": 2028,
    "downside10th": 1.35,
    "base": 3.34,
    "upside90th": 8.26
   },
   {
    "year": 2029,
    "downside10th": 0.9787,
    "base": 2.97,
    "upside90th": 9.01
   },
   {
    "year": 2030,
    "downside10th": 0.7338,
    "base": 2.64,
    "upside90th": 9.52
   }
  ]
 },
 "faqCount": 7,
 "atAGlance": {
  "asOf": "November 10, 2026",
  "rating": "Sell",
  "score": 31,
  "evidence": [
   {
    "label": "Trend",
    "text": "Down: the price is below both its 50- and 200-day moving averages ($6.00 and $10.11)."
   },
   {
    "label": "Earnings",
    "text": "RCAT beat estimates in 1 of its last 5 quarters, yet fell in the first session after that beat."
   },
   {
    "label": "Insiders",
    "text": "Insiders sold $11.5M and made no open-market purchases over the last 18 months."
   }
  ]
 },
 "figures": {
  "asOf": "November 10, 2026",
  "earningsReaction": {
   "quarters": 5,
   "beats": 1,
   "fellFirstSessionAfterBeat": 1,
   "latestReport": "Aug 6, 2026",
   "latestSurprisePercent": -35.29,
   "latestFirstSessionMovePercent": 6.23
  },
  "insiders": {
   "windowMonths": 18,
   "soldValue": 11523901,
   "boughtValue": 0,
   "sales": 13,
   "purchases": 0,
   "note": "open-market transactions only; grants and option exercises excluded"
  },
  "drawdown": {
   "years": 10,
   "worstFallPercent": -99.9,
   "peak": "December 2016",
   "trough": "January 2019",
   "recoveredBy": null,
   "recoveryMonths": null,
   "belowThatPeakNowPercent": -98.59,
   "fromHighNowPercent": -98.59,
   "oneYearHoldsPositivePercent": 45,
   "dividendsReinvested": false
  },
  "seasonality": {
   "years": 10,
   "bestMonth": {
    "month": "Apr",
    "averagePercent": 41.06,
    "upYearsPercent": 40
   },
   "worstMonth": {
    "month": "May",
    "averagePercent": -22.92,
    "upYearsPercent": 30
   }
  },
  "correlations": null,
  "analystTargets": {
   "analysts": 7,
   "low": 6,
   "median": 15,
   "high": 25,
   "mean": 15.57,
   "buy": 6,
   "hold": 1,
   "sell": 0
  },
  "dividend": null,
  "simulation": {
   "year": 2030,
   "base": 2.64,
   "percentile10": 0.7338,
   "percentile90": 9.52,
   "note": "Monte Carlo simulation outcomes, not price targets"
  }
 },
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "ch-overview",
   "title": "RCAT stock today, November 11, 2026: price, news and analyst targets",
   "text": [
    "As of November 10, 2026, Red Cat Holdings Inc. (RCAT) trades at $4.21. Wall Street's median 12-month price target is $15.00 across 7 analysts, 256.3% above the price. CleaRank rates it Sell with a score of 31/100.",
    "Red Cat Holdings Inc. (RCAT) is trading near the bottom of its 52-week range, at 6% of the way from the low to the high, after a 6.44% fall in the last session. The stock sits below its 20-day, 50-day and 200-day averages, and the pressure has built over months: it is down 60.51% over three months and 54.04% over one year. The question for holders is whether the company's rapid revenue growth can outrun a loss-making profile and a persistent run of earnings misses. CleaRank rates the stock Sell with a score of 31 out of 100, which is more cautious than the Buy consensus among Wall Street analysts.",
    "The decline is broad rather than a single shock. Over one month the stock is down 27.04%, over three months 60.51% and over six months 61.83%. The 50-day SMA of $6.00 is now 58.37% below the 200-day SMA of $10.11 in distance terms, meaning the medium-term average has fallen well below the longer-term one, a classic sign of a sustained downtrend. The stock trades 29.85% below its 50-day SMA and 58.37% below its 200-day SMA. The RSI of 39.8 sits in the bearish zone, not yet oversold, which suggests momentum has weakened without a capitulation-style flush.",
    "Of the five most recent reports, only one beat the EPS estimate, the August 14, 2025 report, and that beat was followed by a 10.25% fall in the share price. The August 6, 2026 report was a miss too, with adjusted EPS of -$0.23 against an estimate of -$0.17, yet the stock rose 6.23% in the first session afterwards. Reported EPS over the last twelve months is -$0.80, so the company is not yet earning a profit, and the P/E ratio is not meaningful.",
    "Revenue grew 527.3% in the latest quarter compared with the same quarter a year earlier, far faster than the sector median of 11.7%. Analysts expect revenue of $150.9M this fiscal year, a rise of 270.5%. At $4.21, the stock trades at a price-to-sales ratio of 8.99, against a sector median of 4.0; that puts its P/S 124.8% above the sector median. Net profit margin is -136.27% and operating margin is -191.42%, so each dollar of revenue still comes with a large loss. Debt is light, with a debt-to-equity ratio of 0.03.",
    "Six of seven analysts rate the stock Buy and one rates it Hold, with none at Sell. Needham reaffirmed its Buy rating on October 20, 2026, and Evercore ISI Group started coverage at Outperform on August 31, 2026. Piper Sandler kept a Neutral rating on October 23, 2026, after starting coverage at Neutral on September 2, 2026. Analyst targets run from $6.00 to $25.00, with a median of $15.00. Insiders made 13 sales worth $11.5M over the last 18 months and no open-market purchases. Such sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than purchases would be.",
    "CleaRank score 31/100 (Sell). 3 of 17 checks pass: trend 0 of 4, momentum 1 of 3, valuation and quality 0 of 3, analysts 2 of 3, track record 0 of 4.",
    "Red Cat Holdings Inc. is a drone and robotics company that develops advanced unmanned systems for defense, national security, public safety, and commercial use. The company designs and manufactures small and tactical unmanned aircraft systems, including short-range reconnaissance drones, first-person-view platforms, and extended-range fixed-wing systems for intelligence, surveillance, and reconnaissance missions. Its product portfolio also includes mission management software, ground control systems, and integrated hardware and software solutions that support operations across air, land, and sea."
   ]
  },
  {
   "id": "ch-news",
   "title": "RCAT stock news",
   "text": [
    "October 23, 2026·Piper Sandler",
    "Piper Sandler kept its Neutral rating on October 23, 2026, which means the firm sees no clear upside from current levels. It is one of the few analyst views in the group that is not a Buy.",
    "October 20, 2026·Needham",
    "Needham kept its Buy rating on October 20, 2026. A repeated Buy from a covering firm supports the analyst view that the stock is undervalued relative to its targets.",
    "September 2, 2026·Piper Sandler",
    "Piper Sandler started coverage of the stock at Neutral on September 2, 2026. The starting rating shows a cautious view from a firm that has since kept the same stance.",
    "August 31, 2026·Evercore ISI Group",
    "Evercore ISI Group started coverage at Outperform on August 31, 2026. A new firm starting with an outperform view adds to the positive analyst weight on the stock.",
    "August 6, 2026·Earnings report",
    "The August 6, 2026 report showed adjusted EPS of -$0.23 against an estimate of -$0.17, a 35.29% miss. The stock rose 6.23% in the next session, but the miss keeps the earnings record weak."
   ],
   "lists": {
    "items": [
     "Piper Sandler stays neutral October 23, 2026·Piper Sandler Piper Sandler kept its Neutral rating on October 23, 2026, which means the firm sees no clear upside from current levels. It is one of the few analyst views in the group that is not a Buy.",
     "Needham reaffirms Buy October 20, 2026·Needham Needham kept its Buy rating on October 20, 2026. A repeated Buy from a covering firm supports the analyst view that the stock is undervalued relative to its targets.",
     "New coverage at Neutral September 2, 2026·Piper Sandler Piper Sandler started coverage of the stock at Neutral on September 2, 2026. The starting rating shows a cautious view from a firm that has since kept the same stance.",
     "Evercore starts at Outperform August 31, 2026·Evercore ISI Group Evercore ISI Group started coverage at Outperform on August 31, 2026. A new firm starting with an outperform view adds to the positive analyst weight on the stock.",
     "August report misses estimate August 6, 2026·Earnings report The August 6, 2026 report showed adjusted EPS of -$0.23 against an estimate of -$0.17, a 35.29% miss. The stock rose 6.23% in the next session, but the miss keeps the earnings record weak."
    ]
   }
  },
  {
   "id": "ch-street",
   "title": "RCAT price target 2026",
   "text": [
    "The base case for the coming months is that RCAT stays under pressure until the price can reclaim its moving averages. The price is below the 20-day EMA, the 50-day SMA and the 200-day SMA, and the MACD line is negative, so a recovery would first need to lift the stock above the 20-day EMA and then hold above the 50-day SMA. Revenue is expected to grow 270.5% this fiscal year according to analysts' estimates, but analysts still forecast losses, with an average EPS estimate of -$0.68 for this fiscal year and -$0.44 for next. The analysts' median 12-month target of $15.00 sits far above the price, and six of seven analysts rate the stock Buy, so the gap between Wall Street and the chart is the central tension. Conditions that would improve the picture are a narrowing of losses in upcoming reports and a steady rise in revenue that converts into better margins. Conditions that would worsen it are another EPS miss, a break below the 52-week low of $3.25, or continued insider selling without offsetting buying."
   ],
   "tables": [
    {
     "caption": "Recent analyst rating actions on RCAT",
     "columns": [
      "Date",
      "Firm",
      "Action",
      "Rating"
     ],
     "rows": [
      {
       "label": "Oct 23, 2026",
       "cells": [
        "Piper Sandler",
        "Maintains",
        "Neutral"
       ]
      },
      {
       "label": "Oct 20, 2026",
       "cells": [
        "Needham",
        "Reiterates",
        "Buy"
       ]
      },
      {
       "label": "Sep 2, 2026",
       "cells": [
        "Piper Sandler",
        "Initiates",
        "Neutral"
       ]
      },
      {
       "label": "Aug 31, 2026",
       "cells": [
        "Evercore ISI Group",
        "Initiates",
        "Outperform"
       ]
      },
      {
       "label": "Aug 7, 2026",
       "cells": [
        "HC Wainwright & Co.",
        "Reiterates",
        "Buy"
       ]
      },
      {
       "label": "Aug 7, 2026",
       "cells": [
        "Needham",
        "Maintains",
        "Buy"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "ch-levels",
   "title": "RCAT support and resistance levels",
   "text": [
    "Support sits at the 52-week low of $3.25, the most recent floor the stock has touched and the nearest level below the price. Resistance comes first at the 20-day EMA of $4.66, a level the price would need to clear to show short-term momentum improving. Above that, the 50-day SMA of $6.00 marks the next hurdle, where the stock has been trading before its recent slide. The 200-day SMA of $10.11 is the longer-term trend line, and the 52-week high of $18.78 is the top of the range. A close below $3.25 would put the stock at new lows, while a move through $4.66 would be the first sign that sellers are losing control of the chart."
   ],
   "tables": [
    {
     "caption": "RCAT support and resistance levels",
     "columns": [
      "Level",
      "What it is",
      "Price",
      "From the price"
     ],
     "rows": [
      {
       "label": "Resistance 4",
       "cells": [
        "52-week high",
        "$18.78",
        "+346.1%"
       ]
      },
      {
       "label": "Resistance 3",
       "cells": [
        "200-day moving average",
        "$10.11",
        "+140.2%"
       ]
      },
      {
       "label": "Resistance 2",
       "cells": [
        "50-day moving average",
        "$6.00",
        "+42.6%"
       ]
      },
      {
       "label": "Resistance 1",
       "cells": [
        "20-day exponential average",
        "$4.66",
        "+10.6%"
       ]
      },
      {
       "label": "Price",
       "cells": [
        "November 10, 2026",
        "$4.21",
        ""
       ]
      },
      {
       "label": "Support 1",
       "cells": [
        "52-week low",
        "$3.25",
        "-22.8%"
       ]
      }
     ]
    }
   ],
   "lists": {
    "items": [
     "RSI Bearish",
     "SMA cross Bearish",
     "Price vs SMA Bearish",
     "MACD Bearish"
    ]
   }
  },
  {
   "id": "ch-price",
   "title": "RCAT stock price and trading"
  },
  {
   "id": "ch-fundamentals",
   "title": "RCAT fundamentals and valuation",
   "text": [
    "Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, RCAT trades at 8.99x, +125% versus the sector median of 4.00x.",
    "Return vs XLI: Since May 30, 2025, RCAT has lost 29.2% against a gain of 18.1% for XLI.",
    "Loss-making: RCAT lost $72.1M in FY2025.",
    "Earnings record: RCAT beat the analyst estimate in 1 of the 5 reports in our data.",
    "Market reaction: The stock fell in the first session after that beat, so a beat has not been enough on its own."
   ],
   "tables": [
    {
     "caption": "RCAT earnings surprises and the stock's reaction",
     "columns": [
      "Report",
      "Estimate",
      "Actual",
      "Surprise",
      "First sessionDay 1",
      "5 sessionsDay 5"
     ],
     "rows": [
      {
       "label": "Aug 6, 2026",
       "cells": [
        "-$0.17",
        "-$0.23",
        "-35.29%",
        "+6.23%",
        "+17.99%"
       ]
      },
      {
       "label": "May 7, 2026",
       "cells": [
        "-$0.12",
        "-$0.22",
        "-83.33%",
        "+0.10%",
        "-5.98%"
       ]
      },
      {
       "label": "Nov 13, 2025",
       "cells": [
        "-$0.10",
        "-$0.16",
        "-60.00%",
        "-7.49%",
        "-20.67%"
       ]
      },
      {
       "label": "Aug 14, 2025",
       "cells": [
        "-$0.11",
        "-$0.09",
        "+18.18%",
        "-10.25%",
        "+3.95%"
       ]
      },
      {
       "label": "May 14, 2025",
       "cells": [
        "-$0.10",
        "-$0.27",
        "-170.00%",
        "-2.41%",
        "-4.51%"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "ch-history",
   "title": "RCAT price history and drawdowns",
   "text": [
    "Against the market: RCAT trailed the S&P 500 over this period: $157.15 against $39,967.",
    "A $10,000 investment in RCAT in December 2016 would be worth about $157 today, compared with about $39,967 for the same investment in the S&P 500 benchmark with its dividends reinvested."
   ]
  },
  {
   "id": "ch-scenarios",
   "title": "RCAT stock price prediction 2030",
   "text": [
    "CleaRank's simulation projects a price near $2.64 for RCAT by 2030 in the base case, from $4.21 today (0.6x over 4 years). The 10th-percentile path ends near $0.7338. These are outcomes of a Monte Carlo simulation run on RCAT's historical return distribution, not price targets, and they assume no dividends are reinvested."
   ],
   "tables": [
    {
     "caption": "RCAT simulated price paths by year",
     "columns": [
      "Year",
      "10th percentile",
      "Base case",
      "90th percentile",
      "range base today"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$1.97",
        "$3.75",
        "$7.11",
        ""
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$1.35",
        "$3.34",
        "$8.26",
        ""
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$0.9787",
        "$2.97",
        "$9.01",
        ""
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$0.7338",
        "$2.64",
        "$9.52",
        ""
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "ch-insiders",
   "title": "RCAT insider trading",
   "text": [
    "Net insider selling: No insider bought RCAT shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would."
   ],
   "tables": [
    {
     "caption": "Insider transactions in RCAT",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Oct 15, 2026",
       "cells": [
        "Jeffrey M Thompson Chief Executive Officer",
        "Sell",
        "150.0K",
        "$676.5K"
       ]
      },
      {
       "label": "Oct 2, 2026",
       "cells": [
        "Paul E. Funk II Director",
        "Grant",
        "868",
        "-"
       ]
      },
      {
       "label": "Sep 15, 2026",
       "cells": [
        "Jeffrey M Thompson Chief Executive Officer",
        "Sell",
        "150.0K",
        "$1.2M"
       ]
      },
      {
       "label": "Aug 28, 2026",
       "cells": [
        "Nicholas Reyland Liuzza Jr Director",
        "Sell",
        "65.0K",
        "$552.5K"
       ]
      },
      {
       "label": "Aug 17, 2026",
       "cells": [
        "Jeffrey M Thompson Chief Executive Officer",
        "Sell",
        "150.0K",
        "$1.6M"
       ]
      },
      {
       "label": "Aug 11, 2026",
       "cells": [
        "Nicholas Reyland Liuzza Jr Director",
        "Sell",
        "55.0K",
        "$584.7K"
       ]
      },
      {
       "label": "Aug 11, 2026",
       "cells": [
        "Christopher R. Moe Director",
        "Sell",
        "30.0K",
        "$310.6K"
       ]
      },
      {
       "label": "Jul 15, 2026",
       "cells": [
        "Jeffrey M Thompson Chief Executive Officer",
        "Sell",
        "150.0K",
        "$1.3M"
       ]
      },
      {
       "label": "Jun 11, 2026",
       "cells": [
        "Paul E. Funk II Director",
        "Sell",
        "165.0K",
        "$1.9M"
       ]
      },
      {
       "label": "Apr 30, 2026",
       "cells": [
        "Joseph David Freedman Director",
        "Grant",
        "7.4K",
        "-"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "ch-faq",
   "title": "RCAT stock forecast: questions people ask",
   "text": [
    "How these figures are computed, and where the data comes from: CleaRank methodology."
   ]
  },
  {
   "id": "ch-related",
   "title": "Compare RCAT with similar assets",
   "links": [
    {
     "text": "AVAV AeroVironment, Inc. NASDAQ $123.50 -2.73%",
     "url": "https://clearank.com/stock/aerovironment-avav/"
    },
    {
     "text": "EOSE Eos Energy Enterprises Inc. NASDAQ $1.74 -7.45%",
     "url": "https://clearank.com/stock/eose-stock-analysis/"
    },
    {
     "text": "VRSK Verisk Analytics, Inc. NASDAQ $204.02 +1.70%",
     "url": "https://clearank.com/stock/vrsk-stock-analysis/"
    },
    {
     "text": "CHRW C.H. Robinson Worldwide Inc. NASDAQ $128.92 -0.05%",
     "url": "https://clearank.com/stock/ch-robinson-chrw/"
    },
    {
     "text": "HON Honeywell International Inc. NASDAQ $228.22 -0.34%",
     "url": "https://clearank.com/stock/honeywell-hon/"
    },
    {
     "text": "PPSI Pioneer Power Solutions Inc. NASDAQ $2.22 -1.77%",
     "url": "https://clearank.com/stock/pioneer-power-solutions-ppsi/"
    },
    {
     "text": "GWW W.W. Grainger Inc. NYSE $1,472.91 +1.74%",
     "url": "https://clearank.com/stock/gww-stock-analysis/"
    },
    {
     "text": "HEI HEICO Corporation NYSE $345.09 +0.69%",
     "url": "https://clearank.com/stock/hei-stock-analysis/"
    },
    {
     "text": "VUG vs SCHG Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/vug-vs-schg/"
    },
    {
     "text": "COIN vs HOOD Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/coin-vs-hood/"
    },
    {
     "text": "MKTX vs TW Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/mktx-vs-tw/"
    }
   ]
  }
 ],
 "faq": [
  {
   "question": "What is the RCAT stock forecast?",
   "answer": "The analysts' median 12-month price target is $15.00, which is 256.3% above the current price, with a low of $6.00 and a high of $25.00 across seven analysts. The nearest level below the price is the 52-week low of $3.25. The nearest level above is the 20-day EMA of $4.66."
  },
  {
   "question": "What is the RCAT price target?",
   "answer": "Analysts' 12-month price targets range from a low of $6.00 to a high of $25.00, with a median of $15.00. The consensus rating is Buy, with six of seven analysts rating the stock Buy or strong buy. The current price of $4.21 is well below the median target."
  },
  {
   "question": "Is RCAT a buy or sell today?",
   "answer": "Analysts give the stock a consensus rating of Buy, with six of seven rating it buy or strong buy, one at hold and none at sell. CleaRank rates the stock Sell with a score of 31 out of 100. The stock is below its 20-day EMA, 50-day SMA and 200-day SMA, with the 50-day SMA 42.55% above the price, which reflects a downtrend."
  },
  {
   "question": "Why did RCAT stock fall so much this year?",
   "answer": "The stock is down 54.04% over the past year and 61.83% over six months. The decline has persisted across several months, with the 50-day SMA now far below the 200-day SMA."
  },
  {
   "question": "Is RCAT profitable?",
   "answer": "No. Reported EPS over the last twelve months is -$0.80, and the net profit margin is -136.27%. The company has a debt-to-equity ratio of 0.03, so its balance sheet carries little debt despite the losses."
  },
  {
   "question": "How fast is RCAT revenue growing?",
   "answer": "Revenue grew 527.3% in the latest quarter compared with the same quarter a year earlier, against a sector median of 11.7%. Analysts expect revenue to grow 270.5% this fiscal year to $150.9M."
  },
  {
   "question": "Have insiders been buying RCAT shares?",
   "answer": "No. Insiders made 13 sales worth $11.5M over the last 18 months and made no open-market purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than open-market buying."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "AVAV",
    "name": "AeroVironment, Inc. NASDAQ",
    "price": "$123.50",
    "change": "-2.73%",
    "url": "https://clearank.com/stock/aerovironment-avav/"
   },
   {
    "ticker": "EOSE",
    "name": "Eos Energy Enterprises Inc. NASDAQ",
    "price": "$1.74",
    "change": "-7.45%",
    "url": "https://clearank.com/stock/eose-stock-analysis/"
   },
   {
    "ticker": "VRSK",
    "name": "Verisk Analytics, Inc. NASDAQ",
    "price": "$204.02",
    "change": "+1.70%",
    "url": "https://clearank.com/stock/vrsk-stock-analysis/"
   },
   {
    "ticker": "CHRW",
    "name": "C.H. Robinson Worldwide Inc. NASDAQ",
    "price": "$128.92",
    "change": "-0.05%",
    "url": "https://clearank.com/stock/ch-robinson-chrw/"
   },
   {
    "ticker": "HON",
    "name": "Honeywell International Inc. NASDAQ",
    "price": "$228.22",
    "change": "-0.34%",
    "url": "https://clearank.com/stock/honeywell-hon/"
   },
   {
    "ticker": "PPSI",
    "name": "Pioneer Power Solutions Inc. NASDAQ",
    "price": "$2.22",
    "change": "-1.77%",
    "url": "https://clearank.com/stock/pioneer-power-solutions-ppsi/"
   },
   {
    "ticker": "GWW",
    "name": "W.W. Grainger Inc. NYSE",
    "price": "$1,472.91",
    "change": "+1.74%",
    "url": "https://clearank.com/stock/gww-stock-analysis/"
   },
   {
    "ticker": "HEI",
    "name": "HEICO Corporation NYSE",
    "price": "$345.09",
    "change": "+0.69%",
    "url": "https://clearank.com/stock/hei-stock-analysis/"
   }
  ],
  "comparisons": [
   {
    "ticker": "VUG vs SCHG Comparison",
    "name": "",
    "url": "https://clearank.com/compare/vug-vs-schg/"
   },
   {
    "ticker": "COIN vs HOOD Comparison",
    "name": "",
    "url": "https://clearank.com/compare/coin-vs-hood/"
   },
   {
    "ticker": "MKTX vs TW Comparison",
    "name": "",
    "url": "https://clearank.com/compare/mktx-vs-tw/"
   }
  ],
  "Newly Tracked": [
   {
    "ticker": "BAH",
    "text": "Booz Allen Hamilton Holding Corporation",
    "url": "https://clearank.com/stock/booz-allen-hamilton-bah/"
   },
   {
    "ticker": "FIX",
    "text": "Comfort Systems USA Inc.",
    "url": "https://clearank.com/stock/comfort-systems-fix/"
   },
   {
    "ticker": "AMPX",
    "text": "Amprius Technologies Inc.",
    "url": "https://clearank.com/stock/amprius-technologies-ampx/"
   },
   {
    "ticker": "ACM",
    "text": "AECOM",
    "url": "https://clearank.com/stock/aecom-acm/"
   },
   {
    "ticker": "WYNN",
    "text": "Wynn Resorts, Limited",
    "url": "https://clearank.com/stock/wynn-resorts-wynn/"
   }
  ],
  "Top Movers (latest session)": [
   {
    "ticker": "MRDN",
    "text": "↓ 23.90%",
    "url": "https://clearank.com/stock/mrdn-stock-analysis/"
   },
   {
    "ticker": "HIMS",
    "text": "↓ 16.61%",
    "url": "https://clearank.com/stock/hims-hers-health-hims/"
   },
   {
    "ticker": "LEGN",
    "text": "↓ 15.97%",
    "url": "https://clearank.com/stock/legend-biotech-legn/"
   },
   {
    "ticker": "PL",
    "text": "↑ 14.50%",
    "url": "https://clearank.com/stock/planet-labs-pl/"
   },
   {
    "ticker": "ZEC/USD",
    "text": "↓ 12.04%",
    "url": "https://clearank.com/crypto/zcash-zec-usd/"
   }
  ],
  "Also in Industrials": [
   {
    "ticker": "PL",
    "text": "Planet Labs",
    "url": "https://clearank.com/stock/planet-labs-pl/"
   },
   {
    "ticker": "RDW",
    "text": "Redwire",
    "url": "https://clearank.com/stock/redwire-rdw/"
   },
   {
    "ticker": "RHM",
    "text": "",
    "url": "https://clearank.com/stock/rhm-rheinmetall-ag/"
   },
   {
    "ticker": "RKLB",
    "text": "Rocket Lab",
    "url": "https://clearank.com/stock/rocket-lab-rklb/"
   },
   {
    "ticker": "RTX",
    "text": "RTX Corporation",
    "url": "https://clearank.com/stock/rtx-corporation-rtx/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "alternateName": [
      "CleaRank Financial AI",
      "CleaRank (Clear Rank)"
     ],
     "url": "https://clearank.com",
     "description": "CleaRank is where retail traders research a trade and practice it before risking money. Its research arm, CleaRank Financial AI, publishes daily analysis and 10-year projections for more than 1,000 stocks, ETFs, cryptocurrencies, forex pairs and commodities; each page is built from licensed market data, carries the date it was last updated and is reviewed under CleaRank's published editorial code. The CLEAR™ Score rates online brokers and prop firms on regulation, fees, platform reliability and verified trader experience. The research is free, and so is the Free plan of its trading workbench; CleaRank is paid for by yearly Pro and Unlimited subscriptions to that workbench, which combines a trading simulator, a trade journal that imports from broker history, an AI coach grounded in the trader's own trades, a portfolio generator, visualizer and backtester, a prop-firm challenge auditor and 22 trading calculators and scanners. It uses no affiliate links and takes no payment from the brokers, prop firms or companies it rates or writes about.",
     "slogan": "Clear data. Honest analysis.",
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "image": {
      "@id": "https://clearank.com/#logo"
     },
     "sameAs": [
      "https://x.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank",
      "https://t.me/clearank"
     ],
     "email": "info@clearank.com",
     "contactPoint": [
      {
       "@type": "ContactPoint",
       "contactType": "customer support",
       "email": "info@clearank.com",
       "url": "https://clearank.com/contact/",
       "availableLanguage": "en"
      }
     ],
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "location": {
      "@type": "Place",
      "@id": "https://clearank.com/#place",
      "address": {
       "@type": "PostalAddress",
       "streetAddress": "Beni Berman 2",
       "addressLocality": "Netanya",
       "addressRegion": "Center",
       "postalCode": "4249330",
       "addressCountry": "IL"
      }
     },
     "knowsAbout": [
      "stock analysis",
      "ETF analysis",
      "cryptocurrency analysis",
      "forex trading",
      "trading simulation",
      "trade journaling",
      "position sizing",
      "risk management",
      "prop firm challenges",
      "online broker regulation"
     ],
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "ethicsPolicy": "https://clearank.com/editorial-code/",
     "ownershipFundingInfo": "https://clearank.com/about-us/",
     "owns": {
      "@type": "SoftwareApplication",
      "@id": "https://clearank.com/#app",
      "name": "CleaRank",
      "url": "https://clearank.com/"
     },
     "founder": {
      "@type": "Person",
      "@id": "https://clearank.com/writer/shaundavidb/#person",
      "name": "Shaun David",
      "url": "https://clearank.com/writer/shaundavidb/"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/og/mi/stock/red-cat-rcat.png",
     "url": "https://clearank.com/og/mi/stock/red-cat-rcat.png",
     "width": "1200",
     "height": "630",
     "caption": "Red Cat Holdings Inc. (RCAT) analysis by CleaRank",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/red-cat-rcat/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": 1,
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": 2,
       "item": {
        "@id": "https://clearank.com/stock/",
        "name": "Stocks"
       }
      },
      {
       "@type": "ListItem",
       "position": 3,
       "item": {
        "@id": "https://clearank.com/stock/red-cat-rcat/",
        "name": "Red Cat Holdings Inc. (RCAT)"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/red-cat-rcat/#webpage",
     "url": "https://clearank.com/stock/red-cat-rcat/",
     "name": "Red Cat Holdings (RCAT) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-11-09T13:02:04+00:00",
     "dateModified": "2026-11-10T13:19:23+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/og/mi/stock/red-cat-rcat.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/red-cat-rcat/#breadcrumb"
     },
     "reviewedBy": {
      "@id": "https://clearank.com/writer/anthony-beachey/#person"
     }
    },
    {
     "@type": "Person",
     "@id": "https://clearank.com/writer/anthony-beachey/#person",
     "name": "Anthony Beachey",
     "jobTitle": "Financial Journalist",
     "url": "https://clearank.com/writer/anthony-beachey/",
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     }
    },
    {
     "@type": "Article",
     "@id": "https://clearank.com/stock/red-cat-rcat/#richSnippet",
     "headline": "Red Cat Holdings (RCAT) Stock Forecast & Price Target (2026)",
     "name": "Red Cat Holdings (RCAT) Stock Forecast & Price Target (2026)",
     "description": "Is Red Cat stock a buy? RCAT forecast 2026. The median analyst target is $15. One of the aerospace & defense names we cover.",
     "datePublished": "2026-11-09T13:02:04+00:00",
     "dateModified": "2026-11-10T13:19:23+00:00",
     "author": {
      "@id": "https://clearank.com/#organization"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "publishingPrinciples": "https://clearank.com/market-insights/methodology/",
     "about": {
      "@type": "Corporation",
      "name": "Red Cat Holdings Inc.",
      "identifier": [
       {
        "@type": "PropertyValue",
        "propertyID": "tickerSymbol",
        "value": "RCAT"
       },
       {
        "@type": "PropertyValue",
        "propertyID": "exchange",
        "value": "NASDAQ"
       }
      ],
      "description": "Red Cat Holdings Inc. is a drone and robotics company that develops advanced unmanned systems for defense, national security, public safety, and commercial use.",
      "tickerSymbol": "RCAT",
      "sameAs": "https://redcat.red"
     },
     "isPartOf": {
      "@id": "https://clearank.com/stock/red-cat-rcat/#webpage"
     },
     "image": {
      "@type": "ImageObject",
      "url": "https://clearank.com/og/mi/stock/red-cat-rcat.png",
      "width": 1200,
      "height": 630
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/red-cat-rcat/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "What is the RCAT stock forecast?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The analysts' median 12-month price target is $15.00, which is 256.3% above the current price, with a low of $6.00 and a high of $25.00 across seven analysts. The nearest level below the price is the 52-week low of $3.25. The nearest level above is the 20-day EMA of $4.66."
     }
    },
    {
     "@type": "Question",
     "name": "What is the RCAT price target?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Analysts' 12-month price targets range from a low of $6.00 to a high of $25.00, with a median of $15.00. The consensus rating is Buy, with six of seven analysts rating the stock Buy or strong buy. The current price of $4.21 is well below the median target."
     }
    },
    {
     "@type": "Question",
     "name": "Is RCAT a buy or sell today?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Analysts give the stock a consensus rating of Buy, with six of seven rating it buy or strong buy, one at hold and none at sell. CleaRank rates the stock Sell with a score of 31 out of 100. The stock is below its 20-day EMA, 50-day SMA and 200-day SMA, with the 50-day SMA 42.55% above the price, which reflects a downtrend."
     }
    },
    {
     "@type": "Question",
     "name": "Why did RCAT stock fall so much this year?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The stock is down 54.04% over the past year and 61.83% over six months. The decline has persisted across several months, with the 50-day SMA now far below the 200-day SMA."
     }
    },
    {
     "@type": "Question",
     "name": "Is RCAT profitable?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "No. Reported EPS over the last twelve months is -$0.80, and the net profit margin is -136.27%. The company has a debt-to-equity ratio of 0.03, so its balance sheet carries little debt despite the losses."
     }
    },
    {
     "@type": "Question",
     "name": "How fast is RCAT revenue growing?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Revenue grew 527.3% in the latest quarter compared with the same quarter a year earlier, against a sector median of 11.7%. Analysts expect revenue to grow 270.5% this fiscal year to $150.9M."
     }
    },
    {
     "@type": "Question",
     "name": "Have insiders been buying RCAT shares?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "No. Insiders made 13 sales worth $11.5M over the last 18 months and made no open-market purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than open-market buying."
     }
    }
   ]
  }
 ]
}